Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Rapport Therapeutics (RAPP) Shares Outstanding (2023 - 2026)

Rapport Therapeutics (RAPP) has 4 years of Shares Outstanding data on record, last reported at $47.8 million in Q1 2026.

  • On a quarterly basis, Shares Outstanding rose 30.99% to $47.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was $47.8 million, a 30.99% increase, with the full-year FY2025 number at $47.8 million, up 30.6% from a year prior.
  • Shares Outstanding reached $47.8 million in Q1 2026 per RAPP's latest filing, roughly flat from $47.8 million in the prior quarter.
  • Over the last five years, Shares Outstanding for RAPP hit a ceiling of $47.8 million in Q1 2026 and a floor of $4.2 million in Q3 2023.
  • A 4-year average of $28.6 million and a median of $36.5 million in 2024 define the central range for Shares Outstanding.
  • Peak YoY movement for Shares Outstanding: soared 777.05% in 2024, then decreased 0.22% in 2025.
  • Tracing RAPP's Shares Outstanding over 4 years: stood at $4.2 million in 2023, then skyrocketed by 777.05% to $36.6 million in 2024, then soared by 30.6% to $47.8 million in 2025, then grew by 0.07% to $47.8 million in 2026.
  • Business Quant data shows Shares Outstanding for RAPP at $47.8 million in Q1 2026, $47.8 million in Q4 2025, and $47.7 million in Q3 2025.